|
 |
EDITOR'S PAGE
Alzheimer's Disease and AMD May Share a Common Link
By Conni Bergmann Koury, Editor-in-Chief
MACULA
Real-World Dosing Strategies for Ranibizumab
By Philip J. Rosenfeld, MD, PhD
The Neovascular AMD Treatment Landscape
By Peter K. Kaiser, MD
Triple Therapy for CNV Due to AMD: An Update
By Indre Offermann, MD, and Albert J. Augustin, MD
Omega-3s and Angiogenesis
By Emily Y. Chew, MD
Zinc Found to Be a Link in AMD
By Erik van Kuijk, MD, PhD
Sirolimus and mTOR Inhibition in Ocular Disease:
An Update
By Mark S. Blumenkranz, MD
Topical Multitarget Agent Readying for Phase 2 Trial
By Conni Bergmann Koury, Editor-in-Chief
DIABETES
Emerging Treatments for Diabetic Retinopathy
By Leah D. Farr, Associate Editor
PEDIATRIC RETINA
Current Clinical Management of ROP
By Audina M. Berrocal, MD
MEDICAL RETINA
AWARE Study to Clarify Safety of Anti-VEGF Agents
By Conni Bergmann Koury, Editor-in-Chief
The Rationale for Selective VEGF Inhibition
By Thomas R. Friberg, MD
COVER FOCUS
ARVO Conference Coverage
Continuing Medical Education
Innovations
5 Questions: JAY S. DUKER, MD |
|
|
